216 related articles for article (PubMed ID: 15007564)
1. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
2. IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
Kung MP; Hou C; Zhuang ZP; Zhang B; Skovronsky D; Trojanowski JQ; Lee VM; Kung HF
Brain Res; 2002 Nov; 956(2):202-10. PubMed ID: 12445687
[TBL] [Abstract][Full Text] [Related]
3. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
4. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Zhang W; Kung MP; Oya S; Hou C; Kung HF
Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and characterization of [(124)I]IMPY, a thioflavin-S derivative, in transgenic mouse models of Alzheimer's disease.
Chang KW; Chen CC; Lee SY; Shen LH; Wang HE
Appl Radiat Isot; 2009; 67(7-8):1397-400. PubMed ID: 19307132
[TBL] [Abstract][Full Text] [Related]
6. Iodinated tracers for imaging amyloid plaques in the brain.
Kung HF; Kung MP; Zhuang ZP; Hou C; Lee CW; Plössl K; Zhuang B; Skovronsky DM; Lee VM; Trojanowski JQ
Mol Imaging Biol; 2003; 5(6):418-26. PubMed ID: 14667496
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB
J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119
[TBL] [Abstract][Full Text] [Related]
10. IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
Song PJ; Bernard S; Sarradin P; Vergote J; Barc C; Chalon S; Kung MP; Kung HF; Guilloteau D
Nucl Med Biol; 2008 Feb; 35(2):197-201. PubMed ID: 18312829
[TBL] [Abstract][Full Text] [Related]
11. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
Zhuang ZP; Kung MP; Hou C; Ploessl K; Kung HF
Nucl Med Biol; 2005 Feb; 32(2):171-84. PubMed ID: 15721763
[TBL] [Abstract][Full Text] [Related]
12. Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky DM; Zhang B; Gur TL; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2002; 19(1-2):7-10. PubMed ID: 12212796
[TBL] [Abstract][Full Text] [Related]
13. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
Qu W; Kung MP; Hou C; Benedum TE; Kung HF
J Med Chem; 2007 May; 50(9):2157-65. PubMed ID: 17411026
[TBL] [Abstract][Full Text] [Related]
14. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
Zhuang ZP; Kung MP; Wilson A; Lee CW; Plössl K; Hou C; Holtzman DM; Kung HF
J Med Chem; 2003 Jan; 46(2):237-43. PubMed ID: 12519062
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for beta-amyloid plaques in Alzheimer's disease.
Cui MC; Li ZJ; Tang RK; Liu BL
Bioorg Med Chem; 2010 Apr; 18(7):2777-84. PubMed ID: 20211565
[TBL] [Abstract][Full Text] [Related]
17. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
18. Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain.
Lee CW; Kung MP; Hou C; Kung HF
Nucl Med Biol; 2003 Aug; 30(6):573-80. PubMed ID: 12900283
[TBL] [Abstract][Full Text] [Related]
19. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
20. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
